# Confirmatory Study of OPC-12759 Ophthalmic Solution

> **NCT01660256** · PHASE3 · COMPLETED · sponsor: **Otsuka Pharmaceutical Co., Ltd.** · enrollment: 209 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** OPC-12759
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01660256
- **Lead sponsor:** Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2013-03
- **Final completion:** 2013-05
- **Target enrollment:** 209 (ACTUAL)
- **Last updated:** 2021-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01660256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01660256, "Confirmatory Study of OPC-12759 Ophthalmic Solution". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01660256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*